Marshall Wace North America L.P. - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 170 filers reported holding CARDLYTICS INC in Q3 2021. The put-call ratio across all filers is 2.31 and the average weighting 0.6%.

Quarter-by-quarter ownership
Marshall Wace North America L.P. ownership history of CARDLYTICS INC
ValueSharesWeighting
Q2 2021$3,118,000
-11.0%
24,568
-23.0%
0.01%
-13.3%
Q1 2021$3,503,000
+34930.0%
31,923
+3317.9%
0.02%
Q4 2018$10,000
-96.1%
934
-92.0%
0.00%
-100.0%
Q2 2018$255,000
-68.8%
11,701
-79.1%
0.00%
-75.0%
Q1 2018$818,00055,9190.00%
Other shareholders
CARDLYTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
CAS Investment Partners, LLC 4,488,972$569,785,00024.24%
Antipodean Advisors LLC 638,800$81,083,00022.33%
KPS Global Asset Management UK Ltd 1,126,830$143,029,00017.12%
BRIGHTLIGHT CAPITAL MANAGEMENT LP 319,345$40,534,00014.53%
Oakcliff Capital Partners, LP 236,447$30,012,00012.93%
Alua Capital Management LP 1,244,259$157,934,0008.23%
BERYLSON CAPITAL PARTNERS, LLC 166,700$21,159,0004.69%
683 Capital Management, LLC 911,092$115,644,0004.00%
Covey Capital Advisors, LLC 38,345$4,867,0003.66%
Selkirk Management LLC 70,600$8,961,0003.26%
View complete list of CARDLYTICS INC shareholders